Dividends Calendar Earnings Calendar

CYDY | CytoDyn

CytoDyn
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Vancouver, Washington, United States

Trade prices

  • Volume:
  • Market Cap: 139.05M
  • Prev closed: 0.41
  • Open: 0.42
  • High: 0.47
  • Low: 0.42
  • 52 week low: 0.055
  • 52 week high: 0.71
  • Dividends:No Dividends

Next ER: April 17, 2023  Before Market Opens



Top Stories (CYDY)

    Company Profile

    We are a biotechnology company focused on developing innovative treatments for multiple therapeutic indications. Our lead candidate Leronlimab (PRO 140) belongs to a new class of therapeutics called viral-entry inhibitors and is one of the most advanced experimental monoclonal antibodies for HIV treatment.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 3, 2023-0.02 / -- / -
    February 1, 2023- / -0.04- / -
    January 9, 2023-0.03 / -0.04- / -
    November 2, 2022-0.03 / -0.05- / -
    August 3, 2022-0.15 / -0.04- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Apr 19, 2022 0.2550 0.2599
    0.2650
    0.2501
    1.64M 1.47%
    Apr 18, 2022 0.2513 0.2700
    0.2750
    0.2500
    3.08M -5.17%
    Apr 14, 2022 0.2650 0.3075
    0.3100
    0.2600
    4.75M -11.64%
    Apr 13, 2022 0.2999 0.2800
    0.2999
    0.2620
    3.06M 13.17%
    Apr 12, 2022 0.2650 0.2761
    0.2851
    0.2621
    3.31M -6.09%
    Apr 11, 2022 0.2822 0.3000
    0.3100
    0.2801
    1.84M -7.51%
    Apr 8, 2022 0.3051 0.3100
    0.3300
    0.2800
    3.49M -6.12%
    Apr 7, 2022 0.3250 0.3550
    0.3550
    0.3150
    1.37M -7.17%
    Apr 6, 2022 0.3501 0.3650
    0.3650
    0.3420
    2.02M -2.07%
    Apr 5, 2022 0.3575 0.3701
    0.3750
    0.3502
    736.48K -2.99%
    view more
    NYSE - New York Stock Exchange

    More profiles and info about the company

    • Founded:2002
    • Employees:19

    News

    News for (CYDY)

    This company doesn't provide a dividend.


    Talk about CytoDyn below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Apr 17, 2023 (Same day)

    mtb stt jbht schw els sfbs pnfp 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterFacebookLinkedIn

    Other stocks 

    mcd tjx ma orcl xom symc kmx jbl db mdt lyb xlnx 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet